{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:44:51Z","timestamp":1791114291510,"version":"4.1.0"},"reference-count":28,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T00:00:00Z","timestamp":1267747200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Injection drug users (IDUs) have an elevated risk for carriage of<jats:italic>Staphylococcus aureus<\/jats:italic>, including methicillin-resistant<jats:italic>S. aureus<\/jats:italic>(MRSA). Cutaneous injection-related infections are common in IDUs but detailed studies are few. Based on a subsample of 218 individuals from a community-recruited cohort of IDUs at a supervised injection facility, we investigated the microbiology and related antibiotic susceptibility profiles of isolates from 59 wounds. Twenty-seven percent of subjects had at least one wound and 25 (43%) were culture positive for<jats:italic>S. aureus<\/jats:italic>alone [14 MRSA and 11 (19%) methicillin-susceptible (MSSA) isolates]. Sixteen of 18 MRSA isolates were classified as community associated (CA) by the presence of genes encoding for PVL. MRSA and MSSA occurred in mixed infection with other organisms on three and six occasions, respectively. All CA-MRSA isolates were susceptible to tetracycline, vancomycin and linezolid but only 13% were susceptible to clindamycin compared to 63% of MSSA isolates. The frequency of CA-MRSA is a cause for concern in wound infection in the IDU setting.<\/jats:p>","DOI":"10.1017\/s0950268810000464","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T05:26:00Z","timestamp":1267766760000},"page":"713-720","source":"Crossref","is-referenced-by-count":29,"title":["Community-associated methicillin-resistant<i>Staphylococcus aureus<\/i>is prevalent in wounds of community-based injection drug users"],"prefix":"10.1017","volume":"138","author":[{"given":"E.","family":"LLOYD-SMITH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"HULL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"TYNDALL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"WOOD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S. G.","family":"MONTANER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"KERR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"ROMNEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2010,3,5]]},"reference":[{"key":"S0950268810000464_ref021","doi-asserted-by":"publisher","DOI":"10.1086\/313971"},{"key":"S0950268810000464_ref028","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-120"},{"key":"S0950268810000464_ref020","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-002-0008-0"},{"key":"S0950268810000464_ref026","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.07.003"},{"key":"S0950268810000464_ref025","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-2-24"},{"key":"S0950268810000464_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.08.014"},{"key":"S0950268810000464_ref027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2008.00163.x"},{"key":"S0950268810000464_ref022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055356"},{"key":"S0950268810000464_ref013","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00254-06"},{"key":"S0950268810000464_ref009","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-1-11"},{"key":"S0950268810000464_ref007","doi-asserted-by":"publisher","DOI":"10.4065\/80.9.1201"},{"key":"S0950268810000464_ref015","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-1-9"},{"key":"S0950268810000464_ref019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/BLO.0b013e31811f3526","article-title":"Microbiology of upper extremity soft tissue abscesses in injecting drug abusers","volume":"461","author":"Allison","year":"2007","journal-title":"Clinical Orthopaedics and Related Research"},{"key":"S0950268810000464_ref005","unstructured":"5. Centres for Disease Control and Prevention. Community-associated MRSA Information for Clinicians (http:\/\/www.cdc.gov\/ncidod\/dhqp\/ar_MRSA_ca_clinicians.html). Accessed June 15 2009."},{"key":"S0950268810000464_ref003","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-3-325"},{"key":"S0950268810000464_ref012","volume-title":"Infectious Disease Epidemiology: Theory and Practice","author":"Nelson","year":"2007"},{"key":"S0950268810000464_ref006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01573.x"},{"key":"S0950268810000464_ref001","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.1147-1152.2002"},{"key":"S0950268810000464_ref004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042683"},{"key":"S0950268810000464_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2005.09.002"},{"key":"S0950268810000464_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70689-2"},{"key":"S0950268810000464_ref008","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2007.11.001"},{"key":"S0950268810000464_ref010","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-5-200603070-00005"},{"key":"S0950268810000464_ref002","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.9.947"},{"key":"S0950268810000464_ref024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00377-07"},{"key":"S0950268810000464_ref018","volume-title":"Performance standards for antimicrobial susceptibility testing. Supplement M100-S16","year":"2006"},{"key":"S0950268810000464_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(02)00017-X"},{"key":"S0950268810000464_ref017","doi-asserted-by":"publisher","DOI":"10.1086\/313461"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268810000464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T06:35:52Z","timestamp":1635057352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268810000464\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0950268810000464"],"URL":"https:\/\/doi.org\/10.1017\/s0950268810000464","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,5]]}}}